Letter by Tsuda Regarding Article, "Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial".

Letter by Tsuda Regarding Article, "Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial". Circulation. 2020 Mar 03;141(9):e100-e101 Authors: Tsuda K PMID: 32119586 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32119586?dopt=Abstract

Source: Circulation - March 2, 2020 Category: Cardiology Authors: Tsuda K Tags: Circulation Source Type: research